Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 36: 127790, 2021 03 15.
Artículo en Inglés | MEDLINE | ID: mdl-33454387

RESUMEN

We identified (5R)-6-methyl-5-phenyl-1,3,4,5,6,7-hexahydro-2,5-methano-2,6-benzodiazonine (DS21980956: 4-(R)) as a novel [5.2.1]bicyclic basic compound. The scaffold was inspired by fentanyl or pethidine, which possess potent analgesic activities. DS21980956 had potent analgesic activity in the mouse acetic acid writhing test or tail flick test without agonistic activity at the µ opioid receptor (MOR). The mechanism of analgesic action of DS21980956 was considered to differ from a biased ligand, for example, TRV-130 (3, oliceridine).


Asunto(s)
Aminas/uso terapéutico , Analgésicos/uso terapéutico , Compuestos Bicíclicos Heterocíclicos con Puentes/uso terapéutico , Dolor/tratamiento farmacológico , Ácido Acético , Aminas/química , Analgésicos/química , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Relación Dosis-Respuesta a Droga , Ratones , Ratones Endogámicos , Estructura Molecular , Dolor/inducido químicamente , Dimensión del Dolor , Relación Estructura-Actividad
2.
Bioorg Med Chem Lett ; 28(20): 3333-3337, 2018 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-30217414

RESUMEN

Hepcidin has emerged as the central regulatory molecule in systemic iron homeostasis. The inhibition of hepcidin may be a favorable strategy for the treatment of anemia of chronic disease. Here, we have reported the design, synthesis, and structure-activity relationships (SAR) of a series of 4-aminopyrimidine compounds as inhibitors of hepcidin production. The optimization study of 1 led to the design of a potent and bioavailable inhibitor of hepcidin production, 34 (DS42450411), which showed serum hepcidin-lowering effects in a mouse model of interleukin-6-induced acute inflammation.


Asunto(s)
Aminopiridinas/farmacología , Anemia/tratamiento farmacológico , Hepcidinas/antagonistas & inhibidores , Quinazolinas/farmacología , Administración Oral , Aminopiridinas/administración & dosificación , Aminopiridinas/síntesis química , Aminopiridinas/farmacocinética , Anemia/etiología , Animales , Sitios de Unión , Línea Celular Tumoral , Diseño de Fármacos , Hepcidinas/sangre , Hepcidinas/química , Humanos , Inflamación/inducido químicamente , Inflamación/complicaciones , Interleucina-6/metabolismo , Hierro/metabolismo , Masculino , Ratones Endogámicos C57BL , Estructura Molecular , Quinazolinas/administración & dosificación , Quinazolinas/síntesis química , Quinazolinas/farmacocinética , Relación Estructura-Actividad
3.
Biochem Biophys Res Commun ; 503(4): 2878-2884, 2018 09 18.
Artículo en Inglés | MEDLINE | ID: mdl-30139518

RESUMEN

Hepcidin is a peptide hormone and has emerged as the central molecule regulating systemic iron homeostasis. Hepcidin inhibition could be a strategy for treating anemia of chronic disease. We previously reported the discovery of DS79182026, a new inhibitor of hepcidin production, from phenotypic screening using the human hepatocyte HepG2 cell line. In this study, we utilized a combination of affinity purification-based chemical proteomics and radioactive compound binding assay, and identified several candidate proteins. Purified recombinant proteins were subjected to radioactive compound binding assays for validation, and ALK2 and ALK3 demonstrated specific binding to the compound. Since ALK2 is known to be related to hepcidin production, we focused on ALK2 and found that its knockdown decreased hepcidin expression; we also found a strong correlation (R = 0.920) between pharmacological activity and compound affinity to ALK2. These results indicate that ALK2 is the primary target protein of our new hepcidin production inhibitors.


Asunto(s)
Hepcidinas/antagonistas & inhibidores , Proteómica/métodos , Ensayo de Unión Radioligante/métodos , Receptores de Activinas Tipo I/metabolismo , Anemia/tratamiento farmacológico , Células Hep G2 , Humanos , Unión Proteica , Proteínas/aislamiento & purificación
4.
Bioorg Med Chem Lett ; 27(23): 5252-5257, 2017 12 01.
Artículo en Inglés | MEDLINE | ID: mdl-29079471

RESUMEN

Hepcidin has emerged as the central regulatory molecule in systemic iron homeostasis, and its inhibition could be a favorable strategy for treating anemia of chronic disease (ACD). Here, we report the design, synthesis and structure-activity relationships (SAR) of a series of 4,6-disubstituted indazole compounds as hepcidin production inhibitors. The optimization study of multi-kinase inhibitor 1 led to the design of a potent and bioavailable hepcidin production inhibitor, 32 (DS28120313), which showed serum hepcidin-lowering effects in an interleukin-6-induced acute inflammatory mouse model.


Asunto(s)
Lesión Pulmonar Aguda/tratamiento farmacológico , Descubrimiento de Drogas , Hepcidinas/antagonistas & inhibidores , Indazoles/farmacología , Inflamación/tratamiento farmacológico , Pirazoles/farmacología , Lesión Pulmonar Aguda/inducido químicamente , Administración Oral , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Células Hep G2 , Hepcidinas/biosíntesis , Humanos , Indazoles/administración & dosificación , Indazoles/química , Inflamación/inducido químicamente , Interleucina-6 , Ratones , Estructura Molecular , Pirazoles/administración & dosificación , Pirazoles/química , Relación Estructura-Actividad
5.
Bioorg Med Chem Lett ; 27(16): 3716-3722, 2017 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-28705644

RESUMEN

Hepcidin has emerged as the central regulatory molecule of systemic iron homeostasis. Inhibition of hepcidin could be a strategy favorable to treating anemia of chronic disease (ACD). We report herein the synthesis and structure-activity relationships (SARs) of a series of benzisoxazole compounds as orally active hepcidin production inhibitors. The optimization study of multi kinase inhibitor 1 led to a potent and bioavailable hepcidin production inhibitor 38 (DS79182026), which showed serum hepcidin lowering effects in a mouse IL-6 induced acute inflammatory model.


Asunto(s)
Benzoxazoles/química , Benzoxazoles/farmacología , Carbamatos/química , Carbamatos/farmacología , Hepcidinas/antagonistas & inhibidores , Administración Oral , Animales , Benzoxazoles/administración & dosificación , Benzoxazoles/farmacocinética , Carbamatos/administración & dosificación , Carbamatos/farmacocinética , Regulación de la Expresión Génica/efectos de los fármacos , Semivida , Hepcidinas/genética , Hepcidinas/metabolismo , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Concentración 50 Inhibidora , Interleucina-6 , Maleatos/administración & dosificación , Maleatos/química , Maleatos/farmacocinética , Maleatos/farmacología , Ratones , Ratones Endogámicos C57BL , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/metabolismo , Modelos Animales , Inhibidores de Proteínas Quinasas/administración & dosificación , Inhibidores de Proteínas Quinasas/química , Inhibidores de Proteínas Quinasas/farmacocinética , Inhibidores de Proteínas Quinasas/farmacología , ARN Mensajero/metabolismo , Relación Estructura-Actividad
6.
Bioorg Med Chem Lett ; 27(10): 2148-2152, 2017 05 15.
Artículo en Inglés | MEDLINE | ID: mdl-28377056

RESUMEN

Hepcidin has emerged as the central regulatory molecule of systemic iron homeostasis. Inhibition of hepcidin could be a strategy favorable to treating anemia of chronic disease (ACD). We report herein the synthesis and structure-activity relationships (SARs) of a series of indazole compounds as hepcidin production inhibitors. The optimization study of compound 1 led to a potent hepcidin production inhibitor 45, which showed serum hepcidin lowering effects in a mouse IL-6 induced acute inflammatory model.


Asunto(s)
Antiinfecciosos/síntesis química , Hepcidinas/antagonistas & inhibidores , Indazoles/química , Anemia/tratamiento farmacológico , Anemia/etiología , Animales , Antiinfecciosos/farmacocinética , Antiinfecciosos/uso terapéutico , Enfermedad Crónica , Semivida , Hepcidinas/sangre , Hepcidinas/metabolismo , Indazoles/farmacocinética , Indazoles/uso terapéutico , Concentración 50 Inhibidora , Interleucina-6/toxicidad , Ratones , Ratones Endogámicos C57BL , Microsomas Hepáticos/metabolismo , Relación Estructura-Actividad
7.
Dev Comp Immunol ; 33(10): 1120-7, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19527748

RESUMEN

We previously purified acaloleptin A1, A2, and A3, antibacterial peptides that are produced in the larval hemolymph of Acalolepta luxuriosa (Udo longicorn beetle). In this study, we performed cDNA cloning. The cDNA sequence showed a predicted acaloleptin A precursor that consisted of five acaloleptin A isoforms. Four (isoforms 1, 2, 3 and 4) of the five isoforms of the acaloleptin A precursor had high-level sequence identities with each other, but the N-terminal region of isoform 5 differed from those of the other acaloleptin A isoforms. Northern and Western blot analyses showed that acaloleptin A isoforms were mass-produced soon after bacterial inoculation. Finally, we purified isoform 5 from hemolymph of the immunized larvae. Isoform 5, unlike acaloleptin A1, A2 and A3, showed antimicrobial activities against a Gram-positive bacterium, Micrococcus luteus and a fungus, Magnaporthe grisea. These results suggest that the multipeptide structure of the acaloleptin A precursor allows A. luxuriosa high-level production of antibacterial peptides and resistance to a wide range of microorganisms.


Asunto(s)
Péptidos Catiónicos Antimicrobianos/genética , Proteínas Sanguíneas/genética , Escarabajos/genética , Proteínas de Insectos/genética , Precursores de Proteínas/genética , Secuencia de Aminoácidos , Animales , Péptidos Catiónicos Antimicrobianos/metabolismo , Péptidos Catiónicos Antimicrobianos/farmacología , Secuencia de Bases , Proteínas Sanguíneas/metabolismo , Proteínas Sanguíneas/farmacología , Northern Blotting , Western Blotting , Clonación Molecular , Escarabajos/metabolismo , Escarabajos/microbiología , ADN Complementario/química , ADN Complementario/genética , Cuerpo Adiposo/metabolismo , Hongos/efectos de los fármacos , Hongos/crecimiento & desarrollo , Perfilación de la Expresión Génica , Bacterias Gramnegativas/efectos de los fármacos , Bacterias Gramnegativas/crecimiento & desarrollo , Bacterias Grampositivas/efectos de los fármacos , Bacterias Grampositivas/crecimiento & desarrollo , Hemolinfa/metabolismo , Proteínas de Insectos/metabolismo , Proteínas de Insectos/farmacología , Larva/genética , Datos de Secuencia Molecular , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Análisis de Secuencia de ADN , Análisis de Secuencia de Proteína , Homología de Secuencia de Aminoácido
8.
J Econ Entomol ; 101(5): 1568-74, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18950038

RESUMEN

A mating disruption experiment to control Melanotus okinawensis Ohira (Coleoptera: Elateridae) was conducted at a sugarcane (Saccharum spp.) field and a wild Japanese pampas, Miscanthus sinensis Anderss, grassland on Minami-Daito Island (3,057 ha) from 2001 to 2007. The sugarcane field and the pampas grassland were treated with synthetic sex pheromone that evaporated from a polyethylene tube dispenser. The mean total catches obtained by monitoring traps in the sugarcane fields decreased by 96.1% in 2001 from the previous year on Minami-Daito Island. The mean total trap catches in the treated area further decreased by 74.0% from 2001 until 2007 as cumulative effects. Simultaneously, the number of adults captured by hand decreased from 4.7 per sugarcane field in 2001 to 0.5 in 2007 (89.3% reduction), whereas those captured in the untreated area (Miyagi Island) did not show such a decrease. The mating rates were significantly lower in the females captured in the treated area (14.3-71.4%) than those in the untreated area (96.9-100%). However, the amount of the decrease in the trap catches was relatively small at first (39.6% reduction) in the Japanese pampas grassland on the periphery of the Island. This was probably due to the loss of pheromone substance caused by the strong seasonal wind in the periphery. However, mean total trap catches at the periphery also decreased within several years; significant decreases were detected until 2003, 2006, and 2007. These results indicated that the mating disruption effectively reduced an isolated population of M. okinawensis.


Asunto(s)
Escarabajos/efectos de los fármacos , Control Biológico de Vectores , Atractivos Sexuales/farmacología , Conducta Sexual Animal/efectos de los fármacos , Animales , Escarabajos/fisiología , Femenino , Masculino , Saccharum/parasitología , Estaciones del Año , Razón de Masculinidad
9.
J Immunol ; 177(7): 4594-604, 2006 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-16982897

RESUMEN

To investigate the system used by insects to recognize invading microorganisms, we examined proteins from the larval hemolymph of Bombyx mori that bind to the cell surface of microorganisms. Two hemolymph proteins that bound to the cell surfaces of Micrococcus luteus and Saccharomyces cerevisiae were shown to be identical. This protein bound to all 11 microorganisms examined-5 Gram-negative bacteria, 3 Gram-positive bacteria, and 3 yeasts-and was consequently designated B. mori multibinding protein (BmMBP). The sequence of the cDNA encoding BmMBP revealed that it was a C-type lectin with two dissimilar carbohydrate-recognition domains (CRD1 and CRD2) distantly related to known insect C-type lectins. CRD1 and CRD2 were prepared as recombinant proteins and their binding properties were investigated using inhibition assays. Each domain had wide, dissimilar binding spectra to sugars. These properties enable BmMBP to bind to two sites on a microorganism, facilitating high-affinity binding to many types of microorganisms. The dissociation constants of BmMBP with M. luteus cells and S. cerevisiae were 1.23 x 10(-8) and 1.00 x 10(-11) M, respectively. rBmMBP triggered the aggregation of hemocytes from B. mori larvae in vitro and microorganisms recognized by BmMBP were surrounded by aggregated hemocytes in vivo, forming a nodule, which is the typical cellular reaction in insect immune responses. These observations suggest that BmMBP functions as a trigger for the nodule reaction and that the multirecognition characteristic of BmMBP plays an important role in the early stages of infection by a variety of microorganisms.


Asunto(s)
Bombyx/inmunología , Bombyx/microbiología , Hemolinfa/química , Proteínas de Insectos/metabolismo , Lectinas Tipo C/metabolismo , Secuencia de Aminoácidos , Animales , Bacterias/inmunología , Secuencia de Bases , Western Blotting , Electroforesis en Gel de Poliacrilamida , Hemolinfa/metabolismo , Larva , Lectinas Tipo C/genética , Micrococcus luteus/inmunología , Datos de Secuencia Molecular , Filogenia , Unión Proteica , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/inmunología , Levaduras/inmunología
10.
Comp Biochem Physiol B Biochem Mol Biol ; 142(3): 317-23, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16165382

RESUMEN

We have cloned and characterized a novel antibacterial peptide from the hemolymph of the coleopteran insect Acalolepta luxuriosa, of the superfamily Cerambyocidea. This peptide is active against Micrococcus luteus and Escherichia coli, and the amino acid sequence deduced by cloning of the cDNA identifies it as a coleopteran cecropin. Sequence comparisons and phylogenetic analyses performed using Clustal X suggest that this cecropin is evolutionarily intermediate between dipteran and lepidopteran cecropins. The results of MALDI-TOF mass spectrometry indicate that the mature form of this antibacterial peptide is 35 amino acid residues in length and has an amidated C-terminal isoleucine. This report is the first description of a cecropin from a coleopteran insect.


Asunto(s)
Péptidos Catiónicos Antimicrobianos , Escarabajos/química , ADN Complementario/metabolismo , Proteínas de Insectos , Secuencia de Aminoácidos , Animales , Péptidos Catiónicos Antimicrobianos/clasificación , Péptidos Catiónicos Antimicrobianos/genética , Péptidos Catiónicos Antimicrobianos/aislamiento & purificación , Péptidos Catiónicos Antimicrobianos/metabolismo , Secuencia de Bases , Clonación Molecular , Escherichia coli/metabolismo , Hemolinfa/química , Proteínas de Insectos/clasificación , Proteínas de Insectos/genética , Proteínas de Insectos/aislamiento & purificación , Proteínas de Insectos/metabolismo , Micrococcus luteus/metabolismo , Datos de Secuencia Molecular , Filogenia , Alineación de Secuencia
11.
Biochim Biophys Acta ; 1722(1): 36-42, 2005 Feb 11.
Artículo en Inglés | MEDLINE | ID: mdl-15716136

RESUMEN

We have purified a novel antibacterial peptide from the hemolymph of the coleopteran insect Acalolepta luxuriosa, of the family Cerambyocidae, and named it luxuriosin. This peptide showed growth-inhibitory activity against Micrococcus luteus and germination- and/or growth-inhibitory activity against the conidia from rice blast fungus, Magnaporthe grisea. The amino acid sequence determined by cDNA cloning identified luxuriosin as a peptide of 88 amino acids with a theoretical molecular weight of 10,368.34, containing a Kunitz domain.


Asunto(s)
Péptidos Catiónicos Antimicrobianos , Escarabajos , Proteínas de Insectos , Secuencia de Aminoácidos , Animales , Péptidos Catiónicos Antimicrobianos/genética , Péptidos Catiónicos Antimicrobianos/aislamiento & purificación , Péptidos Catiónicos Antimicrobianos/metabolismo , Secuencia de Bases , Clonación Molecular , Hemolinfa/química , Humanos , Proteínas de Insectos/genética , Proteínas de Insectos/aislamiento & purificación , Proteínas de Insectos/metabolismo , Datos de Secuencia Molecular , Estructura Terciaria de Proteína , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico
12.
Dev Comp Immunol ; 28(1): 1-7, 2004 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-12962978

RESUMEN

An antibacterial peptide from the hemolymph of a coleopteran insect, Acalolepta luxuriosa, in the superfamily Cerambyocidea was characterized. The mature antibacterial peptide had 27 amino acid residues with a theoretical molecular weight of 3099.29 and it showed antibacterial activity against Escherichia coli and Micrococcus luteus. The deduced amino acid sequence of the peptide showed that it had a cysteine-stabilized alphabeta motif with a C...CXXXC...C...CXC consensus sequence, like insect defensins. However, the results of a multiple sequence alignment and phylogenetic analysis with CLUSTAL X indicated that this peptide is a novel peptide with a cysteine-stabilized alphabeta motif that is distant from insect defensins.


Asunto(s)
Antibacterianos/aislamiento & purificación , Escarabajos/química , Escarabajos/genética , Cisteína/química , Péptidos/genética , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Antibacterianos/sangre , Antibacterianos/farmacología , Secuencia de Bases , Clonación Molecular , Escarabajos/clasificación , ADN Complementario/genética , Escherichia coli/efectos de los fármacos , Hemolinfa/química , Micrococcus luteus/efectos de los fármacos , Datos de Secuencia Molecular , Péptidos/química , Péptidos/aislamiento & purificación , Filogenia , Alineación de Secuencia
13.
J Biol Chem ; 277(37): 33742-8, 2002 Sep 13.
Artículo en Inglés | MEDLINE | ID: mdl-12097324

RESUMEN

KK/San is a mutant mouse strain established in our laboratory from KK obese mice. KK/San mice show low plasma lipid levels compared with wild-type KK mice despite showing signs of hyperglycemia and hyperinsulinemia. Recently, we identified a mutation in the gene encoding angiopoietin-like protein 3 (Angptl3) in KK/San mice, and injection of adenoviruses encoding Angptl3 or recombinant ANGPTL3 protein to mutant KK/San mice raised plasma lipid levels. To elucidate the regulatory mechanism of ANGPTL3 on lipid metabolism, we focused on the metabolic pathways of triglyceride in the present study. Overexpression of Angptl3 in KK/San mice resulted in a marked increase of triglyceride-enriched very low density lipoprotein (VLDL). In vivo studies using Triton WR1339 revealed that there is no significant difference between mutant and wild-type KK mice in the hepatic VLDL triglyceride secretion rate. However, turnover studies using radiolabeled VLDL revealed that the clearance of (3)H-triglyceride-labeled VLDL was significantly enhanced in KK/San mice, whereas the clearance of (125)I-labeled VLDL was only slightly enhanced. In vitro analysis of recombinant protein revealed that ANGPTL3 directly inhibits LPL activity. These data strongly support the hypothesis that ANGPTL3 is a new class of lipid metabolism modulator, which regulates VLDL triglyceride levels through the inhibition of LPL activity.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Péptidos y Proteínas de Señalización Intercelular/farmacología , Lipoproteína Lipasa/antagonistas & inhibidores , Lipoproteínas VLDL/metabolismo , Triglicéridos/metabolismo , Proteína 3 Similar a la Angiopoyetina , Proteínas Similares a la Angiopoyetina , Angiopoyetinas , Animales , Lipasa/metabolismo , Lípidos/sangre , Lipoproteína Lipasa/metabolismo , Hígado/enzimología , Masculino , Tasa de Depuración Metabólica , Ratones , Ratones Endogámicos BALB C
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA